This study was designed to assess the effect of maternal diabetes in rats on serum glucose and insulin concentrations, insulin resistance, histological architecture of pancreas and glycogen content in liver of offspring. The pregnant rat females were allocated into two main groups: normal control group and streptozotocin-induced diabetic group. After birth, the surviving offspring were subjected to biochemical and histological examination immediately after delivery and at the end of the 1st and 2nd postnatal weeks. In comparison with the offspring of normal control dams, the fasting serum glucose level of offspring of diabetic mothers was significantly increased at the end of the 1st and 2nd postnatal weeks. Serum insulin level of offspring of diabetic dams was significantly higher at birth and decreased significantly during the following 2 postnatal weeks, while in normal rat offspring, it was significantly increased with progress of time. HOMA Insulin Resistance (HOMA-IR) was significantly increased in the offspring of diabetic dams at birth and after 1 week than in normal rat offspring, while HOMA insulin sensitivity (HOMA-IS) was significantly decreased. HOMA beta-cell function was significantly decreased at all-time intervals in offspring of diabetic dams. At birth, islets of Langerhans as well as beta cells in offspring of diabetic dams were hypertrophied. The cells constituting islets seemed to have a high division rate. However, beta-cells were degenerated during the following 2 post-natal weeks and smaller insulin secreting cells predominated. Vacuolation and necrosis of the islets of Langerhans were also observed throughout the experimental period. The carbohydrate content in liver of offspring of diabetic dams was at all-time intervals lower than that in control. The granule distribution was more random. Overall, the preexisting maternal diabetes leads to glucose intolerance, insulin resistance, and impaired insulin sensitivity and β-cell function in the offspring at different postnatal periods. 1. Introduction Maternal health plays a significant role in determining as well as predicating the health of the offspring later in their life [1]. Fetal exposure to maternal diabetes in utero increases the risk of obesity/adiposity, glucose intolerance, and type 2 diabetes for offspring in later life [2–5]. Little information is available to explain the mechanism of these actions. Animal studies revealed that the offspring of diabetic rats have been shown to be insulin resistant [6, 7] and diabetic [6, 8]. In the case of severe maternal diabetes in
References
[1]
C. Maric-Bilkan, M. Symonds, S. Ozanne, and B. T. Alexander, “Impact of maternal obesity and diabetes on long-term health of the offspring,” Experimental Diabetes Research, vol. 2011, Article ID 163438, 2 pages, 2011.
[2]
G. V. Krishnaveni, S. R. Veena, J. C. Hill, S. Kehoe, S. C. Karat, and C. H. D. Fall, “Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children,” Diabetes Care, vol. 33, no. 2, pp. 402–404, 2010.
[3]
D. J. Pettitt, P. H. Bennett, M. F. Saad, M. A. Charles, R. G. Nelson, and W. C. Knowler, “Abnormal glucose tolerance during pregnancy in Pima Indian women: long-term effects on offspring,” Diabetes, vol. 40, no. 2, pp. 126–130, 1991.
[4]
American Diabetes Association, “Clinical practice recommendations,” Diabetes Care, vol. 29, no. 1, pp. S4–S48, 2006.
[5]
A. Chavey, J. Movassat, and B. Portha, Impact and Mechanisms of Pancreatic β-Cell Mass Programming by Maternal Diabetes—Insight from Animal Model Studies, University Campus STeP Ri Slavka Krautzeka, Rijeka, Croatia, 2011.
[6]
J. Boloker, S. J. Gertz, and R. A. Simmons, “Gestational diabetes leads to the development of diabetes in adulthood in the rat,” Diabetes, vol. 51, no. 5, pp. 1499–1506, 2002.
[7]
V. Grill, B. Johansson, P. Jalkanen, and U. J. Eriksson, “Influence of severe diabetes mellitus early in pregnancy in the rat: effects on insulin sensitivity and insulin secretion in the offspring,” Diabetologia, vol. 34, no. 6, pp. 373–378, 1991.
[8]
F. A. Van Assche, L. Aerts, and K. Holemans, “The effects of maternal diabetes on the offspring,” Baillière's Clinical Obstetrics and Gynaecology, vol. 5, no. 2, pp. 485–492, 1991.
[9]
J. Verhaeghe, T. L. Peeters, M. Vandeputte, W. Rombauts, R. Bouillon, and F. A. Van Assche, “Maternal and fetal endocrine pancreas in the spontaneously diabetic BB rat,” Biology of the Neonate, vol. 55, no. 4-5, pp. 298–308, 1989.
[10]
Y. Song, J. Li, Y. Zhao et al., “Severe maternal hyperglycemia exacerbates the development of insulin resistance and fatty liver in the offspring on high fat diet,” Experimental Diabetes Research, vol. 2012, Article ID 254976, 8 pages, 2012.
[11]
J. Xu and J. Han, “Maternal diabetes increases diabetes risk to offspring,” Pediatrics/Children’s Health, vol. 7, no. 408, 2008.
[12]
E. A. Ryan, D. Liu, R. C. Bell, D. T. Finegood, and J. Crawford, “Long term consequences in offspring of diabetes in pregnancy: studies with syngeneic islet-transplanted streptozotocin-diabetic rats,” Endocrinology, vol. 136, no. 12, pp. 5587–5592, 1995.
[13]
J. Han, J. Xu, Y. Shi Long, P. N. Epstein, and Y. Q. Liu, “Rat maternal diabetes impairs pancreatic β-cell function in the offspring,” Endocrinology and Metabolism: American Journal of Physiology, vol. 293, no. 1, pp. E228–E236, 2007.
[14]
Canadian Council on Animal Care, Guide to the Care and Use of Experimental Animals, vol. 2, Canadian Council on Animal Care, Ottawa, Canada, 1993.
[15]
S. El-Seifi, A. Abdel-Moneim, and N. Badir, “The effect of Ambrosia matitima and Cleome droserfolia on serum insulin and glucose concentration in diabetic rats,” Journal of Egyptian German Society of Zoology, vol. 12, pp. 305–328, 1993.
[16]
S. El-Seifi, B. Ashour, A. Abdel Moneim, and N. Badir, “Effect of Ambrosia maritima, Cleome droserfola and glibenclamide treatment on food and water intake and body weight in diabetic rats,” Journal of Egyptian German Society of Zoology A, vol. 12, pp. 407–426, 1993.
[17]
F. K. Marcondes, F. J. Bianchi, and A. P. Tanno, “Determination of the estrous cycle phases of rats: some helpful considerations,” Brazilian Journal of Biology, vol. 62, no. 4 A, pp. 609–614, 2002.
[18]
P. A. Trinder, “Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor,” Annals of Clinical Biochemistry, vol. 6, pp. 24–25, 1972.
[19]
I. Marschner, P. Bottermann, F. Erhardt et al., “Group experiments on the radioimmunological insulin determination,” Hormone and Metabolic Research, vol. 6, no. 4, pp. 293–296, 1974.
[20]
A. W. Hsing, Y.-T. Gao, S. Chua Jr., J. Deng, and F. Z. Stanczyk, “Insulin resistance and prostate cancer risk,” Journal of the National Cancer Institute, vol. 95, no. 1, pp. 67–71, 2003.
[21]
J. Park, H. Y. Bong, H. N. Jeong, Y. K. Kim, J. Y. Kim, and O. Kwon, “Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats,” Nutrition Research and Practice, vol. 3, no. 4, pp. 272–278, 2009.
[22]
J. D. Bancroft and A. Stevens, Theory and Practice of Histological Techniques, Churchill Livingstone, Edinburgh, Scotland, 2nd edition, 1982.
[23]
M. Roa, K. Blane, and M. Zonneberg, One Way Analysis of Variance, Version IA (C). PC-STAT, University of Georgia, Athens, Ga, USA, 1985.
[24]
A. Jawerbaum and V. White, “Animal models in diabetes and pregnancy,” Endocrine Reviews, vol. 31, no. 5, pp. 680–701, 2010.
[25]
A. R. Quinn, C. L. Blanco, C. Perego et al., “The ontogeny of the endocrine pancreas in the fetal/newborn baboon,” Journal of Endocrinology, vol. 214, no. 3, pp. 289–299, 2012.
[26]
L. Aerts, K. Holemans, and F. A. Van Assche, “Maternal diabetes during pregnancy: consequences for the offspring,” Diabetes/Metabolism Reviews, vol. 6, no. 3, pp. 147–167, 1990.
[27]
B. Reusens-Billen, C. Remacle, J. Daniline, and J. J. Hoet, “Cell proliferation in pancreatic islets of rat fetuses and neonates from normal and diabetic mothers. An in vitro and in vivo study,” Hormone and Metabolic Research, vol. 16, no. 11, pp. 565–571, 1984.
[28]
B. Reusens and C. Remacle, “Intergenerational effect of an adverse intrauterine environment on perturbation of glucose metabolism,” Twin Research, vol. 4, no. 5, pp. 406–411, 2001.
[29]
B. S. Cardell, “Hypertrophy and hyperplasia of the pancreatic islets in newborn infants,” Journal of Pathology & Bacteriology, vol. 66, no. 2, pp. 335–346, 1953.
[30]
F. A. Van Assche, “The Fetal Endocrine Pancreas: A Quantitative Morphological Approach. PhD thesis, University of Leuven,” Biology of the Neonate, vol. 15, no. 34, pp. 176–185, 1970.
[31]
F. P. Charles and D. K. Stephen, “Infant of diabetic mother. eMedicine specialties. pediatrics: cardiac disease and critical care medicine,” Neonatology, 2009.
[32]
A. Kervran, M. Guillaume, and A. Jost, “The endocrine pancreas of the fetus from diabetic pregnant rat,” Diabetologia, vol. 15, no. 5, pp. 387–393, 1978.
[33]
J. B. Meigs, L. A. Cupples, and P. W. F. Wilson, “Parental transmission of type 2 diabetes: The Framingham Offspring Study,” Diabetes, vol. 49, no. 12, pp. 2201–2207, 2000.
[34]
M. H. M. Badawoud, “The effect of maternal diabetes on pancreatic islets in newborn rats: A Quantitative and Immunocytochemical Study,” Folia Morphologica (Warsz), vol. 65, no. 2, pp. 152–156, 2006.
[35]
P. Serradas, M.-N. Gangnerau, M.-H. Giroix, C. Saulnier, and B. Portha, “Impaired pancreatic β cell function in the fetal GK rat: impact of diabetic inheritance,” Journal of Clinical Investigation, vol. 101, no. 4, pp. 899–904, 1998.
[36]
F. Miralles and B. Portha, “Early development of β-cells is impaired in the GK rat model of type 2 diabetes,” Diabetes, vol. 50, supplement 1, pp. S84–S88, 2001.
[37]
R. R. Rodríguez, A. Renauld, D. Celener, R. L. Pérez, and M. C. Susemihl, “Offspring of streptozotocin diabetic rats: size changes in Langerhans islets with time after birth,” Diabetes Research and Clinical Practice, vol. 41, no. 2, pp. 95–100, 1998.
[38]
C. Leloup, C. Magnan, T. Alquier et al., “Intrauterine hyperglycemia increases insulin binding sites but not glucose transporter expression in discrete brain areas in term rat fetuses,” Pediatric Research, vol. 56, no. 2, pp. 263–267, 2004.
[39]
F. Thomas, B. Balkau, F. Vauzelle-Kervroedan, and L. Papoz, “Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group,” Diabetes, vol. 43, no. 1, pp. 63–67, 1994.
[40]
F. M. Matschinsky, A. K. Ghosh, M. D. Meglasson, M. Prentki, V. June, and D. von Allman, “Metabolic concomitants in pure, pancreatic beta cells during glucose-stimulated insulin secretion,” Journal of Biological Chemistry, vol. 261, no. 30, pp. 14057–14061, 1986.
[41]
F. M. Matschinsky and H. W. Collins, “Essential biochemical design features of the fuel-sensing system in pancreatic β-cells,” Chemistry and Biology, vol. 4, no. 4, pp. 249–257, 1997.
[42]
C. E. Ezenwaka, N. V. Offiah, and G. Davis, “Early metabolic defects for developing diabetes mellitus among offspring of patients with type 2 diabetes are independent of gender,” West Indian Medical Journal, vol. 49, no. 4, pp. 276–280, 2000.
[43]
B. Reusens and C. Remacle, “Intergenerational effect of an adverse intrauterine environment on perturbation of glucose metabolism,” Twin Research, vol. 4, no. 5, pp. 406–411, 2001.
[44]
M. Stadler, G. Pacini, J. Petrie, A. Luger, and C. Anderwald, “Beta cell (dys) function in non-diabetic offspring of diabetic patients,” Diabetologia, vol. 52, no. 11, pp. 2435–2444, 2009.
[45]
L. Poston, “Developmental programming and diabetes—The human experience and insight from animal models,” Best Practice & Research: Clinical Endocrinology and Metabolism, vol. 24, no. 4, pp. 541–552, 2010.
[46]
D. J. Petitt, H. B. Baird, K. A. Aleck, P. H. Bennett, and W. C. Knowler, “Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy,” The New England Journal of Medicine, vol. 308, no. 5, pp. 242–245, 1983.
[47]
D. J. Pettitt, K. A. Aleck, H. R. Baird, M. J. Carraher, P. H. Bennett, and W. C. Knowler, “Congenital susceptibility to NIDDM. Role of intrauterine environment,” Diabetes, vol. 37, no. 5, pp. 622–628, 1988.
[48]
R. Kohlhoff and G. Dorner, “Perinatal hyperinsulinism and perinatal obesity as risk factors for hyperinsulinaemia in later life,” Experimental and Clinical Endocrinology, vol. 95, no. 4, pp. 105–108, 1990.
[49]
B. L. Silverman, T. Rizzo, O. C. Green et al., “Long-term prospective evaluation of offspring of diabetic mothers,” Diabetes, vol. 40, supplement 2, pp. 121–125, 1991.
[50]
A. Plagemann, T. Harder, R. Kohlhoff, W. Rohde, and G. D？rner, “Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes,” International Journal of Obesity, vol. 21, no. 6, pp. 451–456, 1997.
[51]
P. W. Franks, H. C. Looker, S. Kobes et al., “Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring,” Diabetes, vol. 55, no. 2, pp. 460–465, 2006.
[52]
J. Han, J. Xu, S. L. Yun, P. N. Epstein, and Y. Q. Liu, “Rat maternal diabetes impairs pancreatic β-cell function in the offspring,” American Journal of Physiology, vol. 293, no. 1, pp. E228–E236, 2007.
[53]
K. Holemans, L. Aerts, and F. A. Van Assche, “Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats,” Diabetologia, vol. 34, no. 2, pp. 81–85, 1991.
[54]
N. L. Gelardi, C. J. Cha, and W. Oh, “Evaluation of insulin sensitivity in obese offspring of diabetic rats by hyperinsulinemic-euglycemic clamp technique,” Pediatric Research, vol. 30, no. 1, pp. 40–44, 1991.
[55]
L. Aerts and F. A. van Assche, “Ultrastructural evaluation of β-cell recruitment in virgin and pregnant offspring of diabetic mothers,” Diabetes Research and Clinical Practice, vol. 41, no. 1, pp. 9–14, 1998.
